AI-based early stage breast cancer screening startup Niramai has raised raised a new round of funding from its existing venture capital investors and Flipkart co-founder Binny Bansal.
Bengaluru, 27 Nov, 2018. RedNewswire/-
Niramai Health Analytix Pvt. Ltd has raised about $6-7 million in a fresh round from early stage investment firms Pi Ventures, Axilor Ventures, Ankur Capital and Flipkart co-founder Binny Bansal, as reported by Economic Times.
The reports are yet to be confirmed by Niramai or any other investor.
Niramai was founded by Geeta Manjunath and Nidhi Mathur, former Xerox Research Center and Hewlett Packard Labs employees in 2016. Niramai is developing an AI-based early stage breast cancer screening device.
It uses a high-resolution thermal sensing device and cloud-hosted analytics solution for analyzing the thermal images. Features include free from harmful radiation, non-invasive, works for women of all ages, portable device and automated detection using machine learning.
It has three products, namely, Sturdy, a compact screening device with cloud processing for specialty hospital, Low-Cost, a handheld device with real-time cloud-based diagnostics for the independent medical practitioner, and a portable solution for large-scale screening.
Niramai is operational across Bengaluru, Mysore, Hyderabad, Mumbai, Dehradun, and Pune in India. Niramai has screened more than 3,000 women and had earlier shared plans of looking to expand across the country through healthcare partners, as well as in a couple of Asian markets by 2019.
Earlier in April 2017, Niramai raised an undisclosed amount of funds from Pi Ventures, Binny Bansal, Axilor Ventures, Ankur Capital, and 500 Startups.